Abstract
The properties of a new antihypertensive agent, SK&F 92657, D,L-3-[2-(3-t-butylamino-2-hydroxypropoxy)phenyl]-6-hydrazinopyridazine, have been studied. The compound, given intravenously, subcutaneously, or orally, caused a sustained fall in systemic blood pressure of conscious genetically hypertensive rats, normotensive cats, and renal hypertensive dogs. The fall in blood pressure of genetically hypertensive rats was maintained during 52 days of chronic dosing with no development of tolerance. The hemodynamic effects and mechanism of action of SK&F 92657 were investigated in anesthetized cats and dogs using a variety of techniques. Blood pressure was lowered by a direct vasodilator effect on precapillary blood vessels (arteries, arterioles), particularly in the renal, coronary, and skeletal muscle vasculatures, giving an overall decrease in total peripheral resistance with no significant change in cardiac output. In contrast, SK&F 92657 had no significant effect on capacitance blood vessel (veins, venules) tone or on vascular reactivity to vasoconstrictors and consequently did not cause postural hypotension. The beta-adrenoceptor-blocking actions of the drug prevented reflex increases in heart rate and cardiac output, except in...Continue Reading
Citations
Jan 1, 1982·European Journal of Clinical Pharmacology·T LüscherW Vetter
Oct 1, 1982·European Journal of Clinical Pharmacology·M G BianchettiW H Ziegler
Jan 1, 1984·Agents and Actions·H Al-FalahiD R Williams
Nov 19, 1991·European Journal of Pharmacology·E M Taylor, M E Parsons
Jan 1, 1994·British Journal of Pharmacology·E M Taylor, A J Kaumann
Jul 1, 1985·Human Toxicology·K C BarnettT F Walker
Mar 26, 2008·Organic & Biomolecular Chemistry·Anna AlbrechtTomasz Janecki
Mar 1, 1987·British Journal of Pharmacology·G AllanM J Follenfant
Jun 1, 1988·British Journal of Pharmacology·M F SimM J Cooling
Jun 1, 1986·The Journal of Pharmacy and Pharmacology·R W GristwoodE M Taylor
May 1, 1986·Human Toxicology·T J SuttonT F Walker
Apr 1, 1988·British Journal of Pharmacology·R W GristwoodD A Owen
Mar 1, 1984·British Journal of Clinical Pharmacology·P L MaliniE Ambrosioni
Dec 1, 1984·Japanese Journal of Pharmacology·K KawashimaH Sokabe